Convertible notes and SAFEs solve the same basic problem, raising early capital without pricing the company, but they are legally different instruments with different consequences if things do not go as planned. Founders often use the two terms interchangeably in conversation, which makes it easy to miss that the choice between them carries real legal and financial weight, not just a difference in paperwork length.
A Convertible Note Is Debt. A SAFE Is Not.
A convertible note is a loan. It carries a principal amount, an interest rate, and a maturity date, and it creates a legal repayment obligation for the company if it is not converted into equity before that maturity date arrives. A SAFE is not debt at all, it has no interest rate and no maturity date in its standard form, and there is no repayment obligation if the company never triggers a conversion event.
What Happens at Maturity
This difference matters most when a company is struggling. If a convertible note reaches its maturity date without a qualifying financing round having happened, the noteholder can, depending on the note's terms, demand repayment of principal plus accrued interest, or in some cases convert at a predetermined valuation regardless of whether a priced round ever happens. A SAFE simply has no equivalent deadline in most modern versions, which removes a real source of pressure on the company during a difficult stretch, but also means the investor has no fallback claim if the company quietly stalls without ever raising again.
Interest Accrual and What It Means for Conversion
A convertible note's accrued interest typically converts into additional equity alongside the principal when the note converts, meaning noteholders end up with more shares than the dollar amount they originally invested would suggest, once accrued interest is factored in. SAFEs carry no interest, so the investor's conversion is based purely on the amount invested, with no accrual effect over time.
Valuation Cap and Discount Work Similarly in Both
Both instruments commonly use a valuation cap, a discount rate, or both, to set the conversion price relative to the priced round that triggers conversion, using the mechanics described in how SAFE conversion actually works. The underlying math for calculating the conversion price is essentially the same whether the instrument is a note or a SAFE, only the presence of accrued interest and a maturity date differ.
What Counts as a Qualifying Financing
Both instruments typically only convert automatically when the triggering round meets a minimum size threshold, often called a qualified financing. A small bridge raise or a handful of additional SAFEs from existing investors usually does not count. This threshold is defined in the instrument itself, and it matters because it determines exactly when conversion becomes mandatory versus optional. A note or SAFE that never encounters a round large enough to qualify can sit outstanding for a long time, which is one more reason both instruments increasingly build in an explicit mechanism for what happens if no qualifying round ever occurs.
Investor Priority in a Wind-Down
Because a convertible note is debt, noteholders generally rank ahead of equity holders, including preferred shareholders, if the company is wound down or liquidated before conversion. SAFE holders, by contrast, are typically treated closer to the bottom of the priority stack in that scenario, since a SAFE is not a debt claim, though the specific priority depends on how the SAFE is drafted and where it falls relative to other SAFEs and any outstanding notes.
Why SAFEs Became More Common for Early Rounds
SAFEs were designed specifically to simplify early-stage fundraising: no interest to track, no maturity date creating a forced deadline, and a shorter, more standardized document that reduces legal costs on both sides. This made them the default instrument for many pre-seed and seed rounds in ecosystems where speed and simplicity matter more than the additional protections a note gives investors.
Why Notes Still Get Used
Convertible notes remain common in specific situations: bridge financings between two priced rounds, jurisdictions or investor bases more comfortable with a traditional debt instrument, and situations where investors specifically want the added protection of a maturity date and interest accrual, particularly when there is real uncertainty about whether the company will raise a priced round again within a reasonable timeframe.
Side Letters and Most Favored Nation Clauses
Both notes and SAFEs are sometimes accompanied by a side letter, a separate agreement granting one investor terms beyond the standard document, most commonly a most favored nation clause. That clause gives the investor the right to adopt more favorable terms if the company later issues a note or SAFE to someone else on better terms. This is common in early rounds where the company is raising from multiple small checks over time, but it means founders need to track every side letter granted, since a generous term offered to a later, smaller investor can retroactively apply to an earlier, larger one through an MFN clause.
Choosing Between Them
The choice usually comes down to what the specific investor is comfortable with and what stage the company is at, more than any universal rule about which instrument is better. A first check from a friendly angel and a bridge round negotiated with an existing institutional investor call for very different instruments, and matching the choice to the situation matters more than defaulting to whichever a founder used last time, the same way choosing between a SAFE and a priced round depends on stage and relationship rather than a fixed formula. Founders raising from multiple sources in the same window sometimes end up using both instruments in parallel, a note for one investor and a SAFE for another, which is workable as long as every outstanding instrument is tracked together and modeled as a single combined conversion event rather than several unrelated ones.